“…The primary antibodies were purchased from GeneTex (D 5 R), Origene (D 1 R), Abcam (3‐nitrotyrosine), Santa Cruz Biotechnology (AT 1 R, D 2 R, SNX2, SNX6, clathrin, HO‐1, NOX1, NOX2, p67 phox ), ProteinTech (SNX1, SNX5), Abbiotec (β‐arrestin), BD Biosciences (IR‐β), Chemicon (LEPR), Millipore (NKA, p47 phox , GAPDH), Bioworld (p22 phox , α 1A ‐AR), and Stressgen Biotechnologies (HO‐2, SOD1, SOD2, SOD3). Some antibodies used are proprietary and previously characterized (D 1 R, D 3 R, D 4 R, ETBR, NOX4) 18‐21 . The antibodies against NHE3, thiazide‐sensitive NaCl cotransporter (NCC), and NKCC2 were gifts from Dr Mark A. Knepper (Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health).…”